Granito A.; Muratori P.; Tovoli F.; Muratori L., Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting, «AUTOIMMUNITY REVIEWS», 2021, 20, Article number: 102787 , pp. 1 - 3 [Scientific article]
Muratori P.; Lenzi M.; Muratori L.; Granito A., Antinuclear antibodies in COVID 19, «CLINICAL AND TRANSLATIONAL SCIENCE», 2021, 14, pp. 1627 - 1628 [Scientific article]Open Access
Munoz-Martinez S.; Sapena V.; Forner A.; Nault J.-C.; Sapisochin G.; Rimassa L.; Sangro B.; Bruix J.; Sanduzzi-Zamparelli M.; Holowko W.; El Kassas M.; Mocan T.; Bouattour M.; Merle P.; Hoogwater F.J.H.; Alqahtani S.A.; Reeves H.L.; Pinato D.J.; Giorgakis E.; Meyer T.; Villadsen G.E.; Wege H.; Salati M.; Minguez B.; Di Costanzo G.G.; Roderburg C.; Tacke F.; Varela M.; Galle P.R.; Alvares-da-Silva M.R.; Trojan J.; Bridgewater J.; Cabibbo G.; Toso C.; Lachenmayer A.; Casadei-Gardini A.; Toyoda H.; Ludde T.; Villani R.; Matilla Pena A.M.; Guedes Leal C.R.; Ronzoni M.; Delgado M.; Perello C.; Pascual S.; Lledo J.L.; Argemi J.; Basu B.; da Fonseca L.; Acevedo J.; Siebenhuner A.R.; Braconi C.; Meyers B.M.; Granito A.; Sala M.; Rodriguez-Lope C.; Blaise L.; Romero-Gomez M.; Pinero F.; Gomez D.; Mello V.; Pinheiro Alves R.C.; Franca A.; Branco F.; Brandi G.; Pereira G.; Coll S.; Guarino M.; Benitez C.; Anders M.M.; Bandi J.C.; Vergara M.; Calvo M.; Peck-Radosavljevic M.; Garcia-Juarez I.; Car, Assessing the impact of COVID-19 on liver cancer management (CERO-19), «JHEP REPORTS», 2021, 3, pp. 1 - 9 [Scientific article]Open Access
Granito A.; Muratori L.; Tovoli F.; Muratori P., Autoantibodies to speckled protein family in primary biliary cholangitis, «ALLERGY, ASTHMA, AND CLINICAL IMMUNOLOGY», 2021, 17, Article number: 35 , pp. 35 - 38 [Scientific article]Open Access
Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sansone V.; Marasco G.; Piscaglia F.; Granito A., Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders, «CANCERS», 2021, 13, Article number: 6376 , pp. 6376 - 6386 [Scientific article]Open Access
Pascolini S.; Vannini A.; Deleonardi G.; Ciordinik M.; Sensoli A.; Carletti I.; Veronesi L.; Ricci C.; Pronesti A.; Mazzanti L.; Grondona A.; Silvestri T.; Zanuso S.; Mazzolini M.; Lalanne C.; Quarneti C.; Fusconi M.; Giostra F.; Granito A.; Muratori L.; Lenzi M.; Muratori P., COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?, «CLINICAL AND TRANSLATIONAL SCIENCE», 2021, 14, pp. 502 - 508 [Scientific article]Open Access
Vito Sansone; Francesco Tovoli; Andrea Casadei-Gardini; Giovan Giuseppe Di Costanzo; Giulia Magini; Rodolfo Sacco; Tiziana Pressiani; Franco Trevisani; Margherita Rimini; Raffaella Tortora; Elena Nardi; Luca Ielasi; Fabio Piscaglia; Alessandro Granito, Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib, «CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY», 2021, 12, Article number: e00286 , pp. 1 - 7 [Scientific article]Open Access
Forgione, A; Tovoli, F; Ravaioli, M; Renzulli, M; Vasuri, F; Piscaglia, F; Granito, A, Contrast-Enhanced Ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features, «GASTROENTEROLOGY INSIGHTS», 2021, 12, pp. 1 - 9 [Scientific article]
Antonella Forgione, Francesco Tovoli, Matteo Ravaioli, Matteo Renzulli, Francesco Vasuri, Fabio Piscaglia, Alessandro Granito, Contrast-enhanced ultrasound LI-RADS LR-5 in hepatic tuberculosis: Case report and literature review of imaging features, «GASTROENTEROLOGY INSIGHTS», 2021, 12, Article number: 12010001 , pp. 1 - 9 [Scientific article]Open Access
Pascolini S.; Granito A.; Muratori L.; Lenzi M.; Muratori P., Coronavirus disease associated immune thrombocytopenia: Causation or correlation?, «WEI-MIAN YU GANRAN ZAZHI», 2021, 54, pp. 531 - 533 [Scientific article]
Granito A.; Pascolini S.; Ricci C.; Ferronato M.; Muratori L.; Vasuri F.; Franceschini T.; Lenzi M.; Muratori P., Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management, «GASTROENTEROLOGY INSIGHTS», 2021, 12, pp. 67 - 75 [Scientific article]Open Access
Granito A.; Muratori L.; Tovoli F.; Muratori P., Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis, «NATURE REVIEWS. RHEUMATOLOGY», 2021, 17, pp. 244 - 245 [Scientific article]
Granito A.; Forgione A.; Marinelli S.; Renzulli M.; Ielasi L.; Sansone V.; Benevento F.; Piscaglia F.; Tovoli F., Experience with regorafenib in the treatment of hepatocellular carcinoma, «THERAPEUTIC ADVANCES IN GASTROENTEROLOGY», 2021, 14, pp. 1 - 19 [Scientific article]Open Access
Granito A.; Muratori L.; Lalanne C.; Quarneti C.; Ferri S.; Guidi M.; Lenzi M.; Muratori P., Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment, «WORLD JOURNAL OF GASTROENTEROLOGY», 2021, 27, pp. 2994 - 3009 [Scientific article]Open Access
Rimini M.; Yoo C.; Lonardi S.; Masi G.; Granito A.; Bang Y.; Rizzato M.D.; Vivaldi C.; Ielasi L.; Kim H.-D.; Bergamo F.; Salani F.; Leoni S.; Ryoo B.-Y.; Ryoo M.-H.; Burgio V.; Cascinu S.; Casadei-Gardini A., Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience, «TARGETED ONCOLOGY», 2021, 16, pp. 653 - 661 [Scientific article]